openPR Logo
Press release

Global Idiopathic Pulmonary Fibrosis Market: Growth Trajectory and Emerging Trends for 2024-2029

Global Idiopathic Pulmonary Fibrosis Market: Growth

What is the Projected Market Size of the Global Idiopathic Pulmonary Fibrosis Market and its Growth Rate?

The global idiopathic pulmonary fibrosis market is projected to witness significant growth over the next few years:
• Market size in 2024: $4.15 billion
• Market size in 2025: $4.39 billion (CAGR of 5.6%)
• Projected market size in 2029: $5.74 billion (CAGR of 7.0%)
This growth can be attributed to factors such as rising disease prevalence, improvements in healthcare infrastructure, and advancements in biomarkers development and diagnostic techniques.

What is Driving the Growth in the Idiopathic Pulmonary Fibrosis Market?
The rise in the prevalence of fibrotic disease is expected to drive the growth of the idiopathic pulmonary fibrosis market going forward. These medical conditions involve an excessive formation and accumulation of fibrous connective tissue in various organs or tissues in the body. Idiopathic pulmonary fibrosis drugs help reduce lung fibrosis and inflammation by targeting multiple signaling pathways involved in fibrosis. For example, according to the American Lung Association, there were approximately 207,000 people affected in the United States and around 58,000 new cases of idiopathic pulmonary fibrosis diagnosed annually. This disease is more common in men than women and mainly affects individuals over 50 years of age.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12579&type=smp

Who Are the Key Players Driving Idiopathic Pulmonary Fibrosis Market Growth?
The key industry players driving the growth of the idiopathic pulmonary fibrosis market include:
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Novartis AG
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Sanofi S.A.
• Gilead Sciences Inc.
• Toray Industries Inc.
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Sun Pharmaceutical Industries Limited
• Shionogi and Co. Ltd.
• Cipla Inc.
• Zydus Lifesciences Ltd.
• Chong Kun Dang Pharmaceutical Corp.
• Kyorin Pharmaceutical Co. Ltd.
• Galapagos NV
• Veracyte Inc.
• Genentech Inc.
• FibroGen Inc.
• GNI Group Ltd.
• Pliant Therapeutics Inc.
• Pulmatrix Inc.
• Galimedix Therapeutics Inc.
• Avalyn Pharma Inc.
• MediciNova Inc.
• Liminal BioSciences Inc.
• Beijing Continent Pharmaceuticals Company
• Galecto Inc.

What Are The Key Trends In The Idiopathic Pulmonary Fibrosis Market?
Significant trends in the idiopathic pulmonary fibrosis market include:
• Advancements in diagnostic techniques
• Emergence of targeted therapies
• Implementation of telemedicine and remote monitoring
• Development and use of combination therapies
• Advancements in lung transplantation

What Are The Segments Of The Global Idiopathic Pulmonary Fibrosis Market?
The global idiopathic pulmonary fibrosis market is segmented into:
1) By Drug Type: Nintedanib, Pirfenidone, Other Drug Types
2) By Mode Of Action: Antifibrotic Agents, Tyrosine Kinase Inhibitors, Other Modes Of Action
3) By Route Of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Providers
5) By End Users: Hospitals And Clinics, Other End Users

Which Region Leads the Idiopathic Pulmonary Fibrosis Market?
In 2024, North America was the largest market for idiopathic pulmonary fibrosis. The Asia Pacific region is expected to register the fastest growth during the forecast period. The market study covers several regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Pre-book the report for swift delivery:
https://www.thebusinessresearchcompany.com/report/idiopathic-pulmonary-fibrosis-global-market-report

What Is Covered In The Idiopathic Pulmonary Fibrosis Market Global Market Report?
- Market Size Analysis: Analyze the Idiopathic Pulmonary Fibrosis Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Idiopathic Pulmonary Fibrosis Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Idiopathic Pulmonary Fibrosis Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Idiopathic Pulmonary Fibrosis Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=12579&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
Learn More About the Business Research Company. With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead. Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Idiopathic Pulmonary Fibrosis Market: Growth Trajectory and Emerging Trends for 2024-2029 here

News-ID: 3835421 • Views:

More Releases from The Business Research Company

Global High-Resolution Anoscopy Market Outlook 2025-2034: Trends, Innovations, And Future Outlook
Global High-Resolution Anoscopy Market Outlook 2025-2034: Trends, Innovations, A …
The High-Resolution Anoscopy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the High-Resolution Anoscopy Market Size and Projected Growth Rate? The market size for high-resolution anoscopy has experienced significant growth over the past few years. The market is predicted to increase from $15.03 billion
Condyloma Acuminata Treatment Market Size Projected To Reach $2.2 Billion By 2034 With A Cagr Of 4%
Condyloma Acuminata Treatment Market Size Projected To Reach $2.2 Billion By 203 …
"The Condyloma Acuminata Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Condyloma Acuminata Treatment Market Size During the Forecast Period? In the past few years, the condyloma acuminata treatment market has seen significant growth. The market value, which is anticipated to
Household Type Fans Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities
Household Type Fans Market Forecast 2025-2034: Comprehensive Analysis And Growth …
"The Household Type Fans Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Household Type Fans Market? The market size for household fans has seen consistent expansion in recent years. The projections indicate an increase from $32.22 billion in 2024
Grain Fumigants Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
Grain Fumigants Industry Report 2025-2034: Market Dynamics, Trends, And Forecast …
The Grain Fumigants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Grain Fumigants Market Size During the Forecast Period? The Grain Fumigants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This

All 5 Releases


More Releases for Idiopathic

Idiopathic Pulmonary Fibrosis Market Size & Share Analysis
The new report published by The Business Research Company, titled Idiopathic Pulmonary Fibrosis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the idiopathic pulmonary fibrosis market size has grown strongly in recent years. It will grow from $3.89
Idiopathic Pulmonary Fibrosis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Idiopathic Pulmonary Fibrosis pipeline landscape. It covers the Idiopathic Pulmonary Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Idiopathic Pulmonary Fibrosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Chronic Idiopathic Myelofibrosis Market 2022 | Detailed Report
The Chronic Idiopathic Myelofibrosis report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry. The Chronic Idiopathic Myelofibrosis report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,
Idiopathic Membranous Nephropathy Treatment Market to Witness Significant Growth …
Idiopathic membranous nephropathy a glomerular disease usually of abrupt onset and associated with the nephrotic syndrome. Membranous nephropathy occurs when the small blood vessels in the kidney (glomeruli), which filter wastes from the blood, become damaged and thickened. As a result, proteins leak from the damaged blood vessels into the urine (proteinuria). R&D in idiopathic membranous nephropathy is expected to aid in growth of the idiopathic membranous nephropathy treatment market. In
Global Idiopathic Scoliosis Treatment Market Size by Type (Infantile Idiopathic, …
Global Idiopathic Scoliosis Treatment‎‎‎‎‎‎‎ Market Research report provides vital information related to the overall market and forecast from 2019 to 2026. This report includes the in-depth analysis of market size, share, growth, trends and regional demand and top layers the Idiopathic Scoliosis Treatment‎‎‎‎‎‎‎ Market. The major players dominating the market are focused upon throughout the by analyzing their revenue, their business summary, product segmentation along with the latest developments. Get Sample
Chronic Idiopathic Constipation Market Research Report 2024
Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipation